New study results challenge the idea that vaccine immunity fades quickly
Tag: mRNA vaccines
UM School of Medicine Researchers Chart Path Forward on Developing mRNA Vaccines for Infections Beyond COVID-19
After helping to develop and test new mRNA technologies for COVID-19 vaccines, University of Maryland School of Medicine (UMSOM) researchers and scientists are turning their attention to utilizing this innovative technology to ward off other infectious diseases like malaria and influenza.
Multistate study examines mRNA vaccine effectiveness for immunocompromised adults during Omicron BA.4 and BA.5 predominance
A new study from the Centers for Disease Control and Prevention’s VISION Network presents and analyzes some of the first real-world data on mRNA COVID vaccine effectiveness during Omicron BA.4 and BA.5 predominance for immunocompromised adults.
2022 Warren Alpert Prize goes to mRNA research that enabled the design of COVID-19 vaccines
The work of the award recipients altered the trajectory of the pandemic and has saved countless lives
The discoveries made by the five scientists have opened the door for an array of mRNA-based therapies and vaccines for a range of diseases, including cancer, heart disease, bleeding disorders, and more
Why Breakthrough COVID? Antibodies Fighting Original Virus May Be Weaker Against Omicron
If you’re wondering why after two vaccination doses and a booster shot, you still got sick from the omicron strain of the virus that causes COVID-19, one possible answer may have been found in a recent study by researchers at Johns Hopkins Medicine and the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH).
With Time and Without Masks, COVID-19 Vaccines Wane in Protection
A study measured effectiveness of COVID-19 mRNA vaccines among health workers, most notably during the emergence of delta virus variant and coincident with end of state’s mask mandate, finding protection waned over time, dropping sharply 6-8 months after full vaccination.
Hopkins Med News Update
News stories in this issue
COVID-19 vaccine generates immune structures critical for lasting immunity
A new study from researchers at Washington University School of Medicine in St. Louis, published June 28 in the journal Nature, has found evidence that the immune response to Pfizer’s mRNA vaccine against COVID-19 is both strong and potentially long-lasting.
Had COVID-19? One vaccine dose enough; boosters for all, study says
A new study in ACS Nano supports increasing evidence that people who had COVID-19 need only one vaccine dose, and that boosters could be necessary for everyone in the future.
ACAAI Updates Guidance on Risk of Allergic Reactions to COVID-19 Vaccines
An update from the ACAAI COVID-19 Vaccine Task Force on the risk of allergic reactions to COVID-19 vaccines – including the Johnson & Johnson vaccine
An mRNA vaccine for cancer immunotherapy
Researchers reporting in ACS’ Nano Letters have developed a hydrogel that, when injected into mice with melanoma, slowly released RNA nanovaccines that shrank tumors and kept them from metastasizing.